Notably, the PEBL-transduced NKG2Anull NK cells displayed a more effective antitumor capacity against HLA-E+ tumor cells in vivo than blockade with anti-NKG2A mAb (114, 115). This evidence concerns the gene HLA-E and neoplasm.